Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (9): 570-571.
DOI: 10.19803/j.1672-8629.2019.09.11
Previous Articles Next Articles
HONG Yanyan, HONG Zhenxian, CHEN Zhimin*
Received:2019-01-21
Revised:2019-10-21
Online:2019-09-20
Published:2019-10-21
CLC Number:
HONG Yanyan, HONG Zhenxian, CHEN Zhimin. One Case of Bronchial Spasm Induced by Ademetionine 1,4-butanedisulfonate for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 570-571.
| [1] 李昱江,诸葛宇征. S-腺苷蛋氨酸在肝脏疾病发生发展中作用的研究进展[J].东南大学学报(医学版),2012,31(5):661-664. [2] 刘艳芳,张宏玮,邢铭友.丁二磺酸腺苷蛋氨酸致过敏性荨麻疹1例[J].医药导报,2009,28(7):864. [3] 蔡少平,常秀娟,刘泽.丁二磺酸腺苷蛋氨酸致呼吸困难[J].药物不良反应杂志,2008,10(5):321. [4] 杨霞,于磊,谢宇,等.注射用丁二磺酸腺苷蛋氨酸致呼吸困难和血压升高[J].药物不良反应杂志,2017,19(4):310-311. [5] 张美祥,王树平,汪曲.注射用丁二磺酸腺苷蛋氨酸致注射部位肿痛1 例[J].医药导报,2014,33(7):971. [6] 朱瑜,范洁,黄小萍.注射用丁二磺酸腺苷蛋氨酸致外周静脉炎2例[J].药物流行病学杂志,2013,22(7):400. [7] 孙敏,王娟,曹凯,等.丁二磺酸腺苷蛋氨酸致静脉炎1 例[J].中国药物警戒,2014,11(12):764. [8] 张春梅,周俊卿.静脉滴注注射用丁二磺酸腺苷蛋氨酸溶剂使用不当致局部疼痛、红肿2例[J].临床合理用药杂志,2016,9(19):128. [9] 王薇薇,王应军,毛新妍.合理使用注射用丁二磺酸腺苷蛋氨酸的几点建议[J].北方药学,2014,11(6):23. [10] 谢奕丹. 可疑丁二磺酸腺苷蛋氨酸相互作用引起呕吐1例[J].实用医学杂志,2014,30(23):3 886-3 887. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
